High Expression of MTA1 Predicts Unfavorable Survival in Patients With Oral Squamous Cell Carcinoma

被引:6
作者
Lin, Kuan-Yu [1 ]
Su, Tzu-Cheng [2 ]
Yeh, Chung-Min [2 ,3 ]
Chao, Wan-Ru [1 ,4 ,5 ]
Sung, Wen-Wei [1 ,6 ,7 ]
机构
[1] Chung Shan Med Univ, Sch Med, 110,Sect 1,Jianguo N Rd, Taichung 40201, Taiwan
[2] Changhua Christian Hosp, Dept Pathol, Changhua, Taiwan
[3] Jen Teh Jr Coll Med Nursing & Management, Dept Med Technol, Miaoli, Taiwan
[4] Chung Shan Med Univ, Dept Pathol, Taichung, Taiwan
[5] Chung Shan Med Univ Hosp, Dept Pathol, Taichung, Taiwan
[6] Chung Shan Med Univ, Inst Med, Taichung, Taiwan
[7] Chung Shan Med Univ Hosp, Dept Urol, Taichung, Taiwan
来源
IN VIVO | 2021年 / 35卷 / 04期
关键词
Metastasis-associated protein 1; MTA1; prognosis; oral squamous cell carcinoma; overall survival; MAMMARY ADENOCARCINOMA; NUCLEAR EXPRESSION; CANCER; METASTASIS; ESTROGEN; PROMOTES; PROGRESSION; COMPLEX; GENE; NURD;
D O I
10.21873/invivo.12513
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background/Aim: Metastasis-associated protein 1 (MTA1) plays a role in ATP-dependent nucleosome disruption activity and histone deacetylase activity and may indicate DNA methylation activity. MTA1 may also be involved in the progression of oral squamous cell carcinoma (OSCC). Patients and Methods: MTA1 immunoreactivity was analyzed using immunohistochemical (IHC) staining analysis in specimens from 281 OSCC patients. Kaplan-Meier analysis was used to determine the prognostic value of MTA1 for overall survival. Results: High MTA1 expression was significantly associated with female gender and lymph node metastasis. Multivariate analyses showed the independent prognostic role of high MTA1 expression in patients with OSCC of poorer mean survival. Conclusion: MTA1 expression, detected by IHC staining, could be an independent prognostic marker for patients of OSCC.
引用
收藏
页码:2363 / 2368
页数:6
相关论文
共 39 条
[31]  
TOH Y, 1994, J BIOL CHEM, V269, P22958
[32]   NURD, a novel complex with both ATP-dependent chromatin-remodeling and histone deacetylase activities [J].
Xue, YT ;
Wong, JM ;
Moreno, GT ;
Young, MK ;
Côté, J ;
Wang, WD .
MOLECULAR CELL, 1998, 2 (06) :851-861
[33]   Estrogen and progesterone receptors in breast cancer [J].
Yip, Cheng-Har ;
Rhodes, Anthony .
FUTURE ONCOLOGY, 2014, 10 (14) :2293-2301
[34]  
Yu CH, 2007, J DENT SCI, V2, P1
[35]   Expression of MTA1 in nasopharyngeal carcinoma and its correlation with prognosis [J].
Yuan, Taize ;
Zhang, Huanhuan ;
Liu, Baoqiong ;
Zhang, Qiong ;
Liang, Yin ;
Zheng, Ronghui ;
Deng, Jin ;
Zhang, Xiuping .
MEDICAL ONCOLOGY, 2014, 31 (12) :1-8
[36]   Crosstalk between ATF4 and MTA1/HDAC1 promotes osteosarcoma progression [J].
Zeng, Heng ;
Zhang, Jin-ming ;
Du, Yu ;
Wang, Jiang ;
Ren, Ye ;
Li, Mi ;
Li, Hao ;
Cai, Zhuo ;
Chu, Qian ;
Yang, Caihong .
ONCOTARGET, 2016, 7 (06) :7329-7342
[37]   Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation [J].
Zhang, Y ;
Ng, HH ;
Erdjument-Bromage, H ;
Tempst, P ;
Bird, A ;
Reinberg, D .
GENES & DEVELOPMENT, 1999, 13 (15) :1924-1935
[38]   MTA1-upregulated EpCAM is associated with metastatic behaviors and poor prognosis in lung cancer [J].
Zhou, Ning ;
Wang, Haijuan ;
Liu, Hongxu ;
Xue, Hongsheng ;
Lin, Feng ;
Meng, Xiting ;
Liang, Ailing ;
Zhao, Zhilong ;
Liu, YongJun ;
Qian, Haili .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2015, 34
[39]   Metastasis-Associated Protein 1 Nuclear Expression is Associated with Tumor Progression and Clinical Outcome in Patients with Non-small Cell Lung Cancer [J].
Zhu, Xiaoxia ;
Guo, Yu ;
Li, Xiangzhao ;
Ding, Yanqing ;
Chen, Longhua .
JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (08) :1159-1166